Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Nevro Corp (1N7N)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
11.6000 -0.3000    -2.52%
02:05:49 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US64157F1030 
S/N:  A12EPL
  • Volume: 0
  • Bid/Ask: 10.8000 / 10.9000
  • Day's Range: 11.6000 - 11.6000
Nevro Corp 11.6000 -0.3000 -2.52%

Nevro Corp Company Profile

 
Get an in-depth profile of Nevro Corp, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

1087

Equity Type

ORD

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.

Contact Information

Address 1800 Bridge Parkway
Redwood City, 94065
United States
Phone 650 251 0005
Fax -
Web nevro.com

Top Executives

Name Age Since Title
Frank M. Fischer 81 2012 Independent Director
Michael F. DeMane 66 2011 Independent Lead Director
Karen N. Prange 59 2019 Independent Director
Shawn T. McCormick 59 2014 Independent Director
Elizabeth H. Weatherman 63 2019 Independent Director
Sridhar N. Kosaraju 45 2021 Independent Director
Kevin C. O’Boyle 67 2019 Independent Director
Susan E. Siegel 62 2020 Independent Director
D. Keith Grossman 64 2019 Non-Executive Chairman of the Board
Kirt Paul Karros 55 2024 Independent Director
Kevin R. Thornal 50 2023 President, CEO & Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NVRO Comments

Write your thoughts about Nevro Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
aung khant
aung khant Aug 05, 2021 7:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
whoo
WILLJ JK
WILLJ JK Jan 15, 2021 7:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Focus: Industrials spike to major resistance, Retail sector clears key trendline, Boeing takes flight, Apple extends triangle breakout, XLI, XRT, BA, AAPL, NVRO https://www.marketwatch.com/story/charting-a-bull-flag-breakout-sp-500-knifes-within-view-of-record-high-3028-2019-09-12?mod=mw_quote_news
WILLJ JK
WILLJ JK Jan 15, 2021 7:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nevro price target raised to $205 from $175 at Truist Securities, stock rated buy
WILLJ JK
WILLJ JK Jan 15, 2021 5:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nevro to Highlight New Clinical Evidence at the 2021 North American Neuromodulation Society (NANS) Virtual Meeting
Peter Smith
Peter Smith Jan 14, 2021 12:41PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
DUMP!! No earnings! not a "value" company!!
Super Vicious
Super Vicious Dec 09, 2019 10:56AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
going down
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email